*

Penny Stock DD

Contract drug developer Pharmaceutical Product Development Inc. said Tuesday that its first-quarter net income surged on a boost in revenue from clinical development services.

PPD earned $37.6 million, or 32 cents per share, up from profit of $17.2 million, or 14 cents per share, during the same period a year prior. Revenue rose nearly 11 percent to $383.2 million from $346.8 million.

Analysts polled by FactSet had expected 33 cents per share in profit on $361.9 million in revenue.

In January, the company set guidance for 2011. It expects to earn between $1.53 and $1.69 per share in 2011 on revenue of $1.48 billion to $1.58 billion. Analysts have forecast full-year profit of $1.62 per share on $1.53 billion in revenue.

Full article

Regards,

Don

Leave a Reply

Performance Optimization WordPress Plugins by W3 EDGE